A Phase 1 Dose Escalation Study to Investigate Safety, Tolerability, and Pharmacokinetics of ANAVEX 2-73 in Healthy Male Subjects.

CNS Summit 2014, Boca Raton, FL

Ole Voges, Ingo Weigmann, Norman Bitterlich, Christoph Schindler and Christopher Missling

View Poster

Share this: